883 results match your criteria: "Patient-centered Outcomes[Affiliation]"

Article Synopsis
  • This study looked at patients who had a special heart procedure called PCI from 2018 to 2021 to see how often serious problems happened after the procedure.
  • It found that 3.5% of patients had problems, and if they did, their chances of dying in the hospital were much higher (about 19.7%) compared to those without problems (1.3%).
  • The research also showed that the risk of dying from these problems increased over time, and different hospitals had different success rates in preventing this from happening.
View Article and Find Full Text PDF
Article Synopsis
  • * The CSS was developed using five key symptoms (pain, fatigue, shortness of breath, muscle weakness, coughing) identified from the MD Anderson Symptom Inventory for MPM and showed a strong correlation with other established symptom measurement scales.
  • * This new score is user-friendly, allowing for frequent electronic administration, making it a valuable tool for assessing symptom changes during clinical trials and improving patient management in practice.
View Article and Find Full Text PDF

Purpose: Medication adherence is crucial for achieving clinical goals. Medication adherence drivers and behaviors were explored across multiple conditions, countries, and medication schedules/modalities to develop a conceptual model of medication adherence, which could later be used to support development of a patient-reported outcome (PRO) measure of adherence.

Patients And Methods: Targeted review of qualitative literature identified important medication adherence concepts.

View Article and Find Full Text PDF

Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression - Depression subscale scores by administration mode: An individual participant data differential item functioning meta-analysis.

J Affect Disord

September 2024

Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Psychology, McGill University, Montréal, Québec, Canada; Biomedical Ethics Unit, McGill University, Montréal, Québec, Canada.

Article Synopsis
  • * Statistically significant differential item functioning (DIF) was found for most questionnaire items, but this had minimal impact on total scores.
  • * Researchers and clinicians can choose the administration method based on what works best for patients, considering preferences, feasibility, or cost, as score differences were negligible.
View Article and Find Full Text PDF
Article Synopsis
  • - The ACTIV-4c trial examined the effectiveness of apixaban, given for 30 days after hospital discharge from COVID-19, but was halted early due to low rates of death or thromboembolism.
  • - Researchers aimed to find high-risk patients for whom post-discharge blood clot prevention might be beneficial by analyzing various factors like age, ethnicity, and D-dimer levels.
  • - Results showed that the overall occurrence of death and thromboembolism was low, especially in patients under 60, and the study concluded that there was no clear high-risk group that would benefit from additional blood clot prevention measures.
View Article and Find Full Text PDF

Background And Objectives: Although prior research has shown that social relationships and daily stress are strongly associated with cognitive function, few studies have explored the link between the quality of daily social encounters and subjective cognitive decline (SCD). The present study explores whether the quality of older adults' daily social encounters is associated with SCD through daily stress.

Research Design And Methods: This study used data from 254 adults aged 70 or older (  = 76.

View Article and Find Full Text PDF

When health-related research funding agencies choose to fund research, they balance a number of competing issues: costs, stakeholder views and potential benefits. The REWARD Alliance, and the related Lancet-REWARD Campaign, question whether those decisions are yielding all the value they could. A group of health-related research funding agencies, organisations that represent health-related research funding agencies and those that inform and set health-related-research funding policy from around the world have come together since 2016 to share, learn, collaborate and influence emerging practice.

View Article and Find Full Text PDF

Given the high and growing prevalence of obesity among adults in the United States, obesity treatment and prevention are important topics in biomedical and public health research. Although researchers recognize the significance of this problem, much remains unknown about safe and effective prevention and treatment of obesity in adults. In response to the worsening obesity epidemic and the many unknowns regarding the disease, a group of key scientific and program staff members of the National Institutes of Health (NIH) and other federal and non-government agencies gathered virtually in September 2021 to discuss the current state of obesity research, research gaps, and opportunities for future research in adult obesity prevention and treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - Sensor-based digital health technology (DHT) uses sensors to improve understanding of patient health by providing data on functioning both in and out of clinical trials, enhancing the patient experience for medical product development.
  • - The paper outlines recommendations for defining sensor-based functional outcomes (SBFOs), the necessary evidence to support their use in decision-making, and future directions for this emerging field.
  • - Successful SBFO development relies on a combination of expertise in patient engagement, measurement science, and analytics, while addressing challenges such as identifying meaningful health concepts and establishing thresholds for change, making SBFOs valuable alongside traditional clinical outcome assessments.
View Article and Find Full Text PDF

Women with intellectual and developmental disabilities (I/DD) are less likely to receive cervical cancer screening (CCS) relative to women without disabilities. Primary care providers (PCPs) play key roles in recommending CCS. The purpose of this study was to identify factors PCPs consider when recommending and performing CCS for women with I/DD.

View Article and Find Full Text PDF

What Is This Summary About?: This summary describes what researchers learned during interviews of women with uterine fibroids and heavy menstrual bleeding (or period bleeding). At this time, little is known about how women perceive the impact of uterine fibroids on their lives and more information is needed. The goal of this study was to provide new information about the symptoms women have and how these symptoms affect their everyday lives.

View Article and Find Full Text PDF

Purpose: This study examined the effectiveness and feasibility of the Active Living After Cancer (ALAC) program for metastatic breast cancer (MBC) survivors.

Methods: ALAC is a 12-session community-based program to help cancer survivors improve their physical functioning and quality of life through increased physical activity. ALAC participants with MBC (stage IV) were compared to survivors with early-stage breast cancer (stages I and II).

View Article and Find Full Text PDF

Framework of the strengths and challenges of clinically integrated trials: An expert panel report.

Am Heart J

September 2024

Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC. Electronic address:

The limitations of the explanatory clinical trial framework include the high expense of implementing explanatory trials, restrictive entry criteria for participants, and redundant logistical processes. These limitations can result in slow evidence generation that is not responsive to population health needs, yielding evidence that is not generalizable. Clinically integrated trials, which integrate clinical research into routine care, represent a potential solution to this challenge and an opportunity to support learning health systems.

View Article and Find Full Text PDF

Introduction: Canine osteoarthritis (OA) causes pain and mobility impairment. This can reduce dog quality of life (QoL), owner QoL and owners' satisfaction with, and adherence to, treatments. No existing canine OA-specific instrument assesses all three impacts.

View Article and Find Full Text PDF

Background And Aims: Incident heart failure (HF) among individuals with chronic kidney disease (CKD) incurs hospitalizations that burden patients and health care systems. There are few preventative therapies, and the Pooled Cohort equations to Prevent Heart Failure (PCP-HF) perform poorly in the setting of CKD. New drug targets and better risk stratification are urgently needed.

View Article and Find Full Text PDF
Article Synopsis
  • Missed lesions during colonoscopy can lead to post-procedure colorectal cancer, prompting the development of contrast-enhanced technologies like linked color imaging (LCI) for better polyp detection.
  • A national, randomized trial compared polyp detection rates between standard white-light imaging (WLI) and LCI in the right colon, involving 764 patients across 10 endoscopy units.
  • Results showed no significant difference in the proximal adenoma miss rate or miss rates for other types of lesions between the WLI-first and LCI-first groups, challenging the idea that LCI improves detection in routine colonoscopy.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to determine if low-dose oral misoprostol is more effective than intravenous oxytocin in continuing uterine stimulation after cervical ripening and membrane rupture in women induced for hypertensive pregnancy issues.
  • - In a trial involving 520 women, results showed that the caesarean section rates were not significantly different between the two groups, and the time from randomization to birth was longer for those receiving misoprostol.
  • - Although there were no major safety concerns like hyperstimulation, fewer babies required special care in the misoprostol group, and there were no neonatal deaths reported compared to three in the oxytocin group.
View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on the risk of late ventricular tachycardia (VT) and ventricular fibrillation (VF) in patients who have undergone primary percutaneous coronary intervention (PCI) for STEMI, noting that while mortality risk is low, incidents of VT and VF may occur post-procedure.
  • Researchers analyzed data from 174,126 patients treated with primary PCI between 2015 and 2018, discovering that 8.9% experienced VT or VF, with 2.4% specifically having late VT or VF occurring after the procedure.
  • The study identified demographic data showing a median age of 63 for patients with late VT or VF, and the findings highlight
View Article and Find Full Text PDF

The functional Scale for the Assessment and Rating of Ataxia (f-SARA) assesses Gait, Stance, Sitting, and Speech. It was developed as a potentially clinically meaningful measure of spinocerebellar ataxia (SCA) progression for clinical trial use. Here, we evaluated content validity of the f-SARA.

View Article and Find Full Text PDF

How nicotine is administered has evolved from cigarettes to various delivery systems. Assessing perceived dependence on nicotine-containing products now requires accounting for product specificity while allowing comparisons across products and users. This study aims to develop a new self-report measure to assess perceived dependence on tobacco and nicotine products (TNPs) among exclusive and poly-TNP users.

View Article and Find Full Text PDF

Purpose: Lung cancer survivors have more psychosocial problems, including depression and anxiety disorder, than other cancer survivors. Lung cancer-specific symptoms, such as cough, dyspnea, or pain in chest, might increase FCR among survivors. We aimed to evaluate the association between lung cancer-specific symptoms and FCR among recurrence-free non-small cell lung cancer (NSCLC) survivors.

View Article and Find Full Text PDF

Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis.

Cancer

August 2024

Department of Physiological Nursing, Bakar Computational Health Sciences Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.

Article Synopsis
  • The study investigates the link between cancer-related cognitive impairment (CRCI) and anxiety in cancer patients, aiming to uncover the biological mechanisms behind their co-occurrence.
  • Researchers analyzed data from 451 patients undergoing chemotherapy, categorizing them based on levels of CRCI and anxiety, and identified five disrupted neurodegenerative disease pathways.
  • Key processes such as apoptosis and oxidative stress were common across these pathways, suggesting potential targets for future therapeutic interventions.
View Article and Find Full Text PDF

Background: The Near Visual Acuity Questionnaire Presbyopia (NAVQ-P) is a patient-reported outcome (PRO) measure that was developed in a phakic presbyopia population to assess near vision function impacts. The study refined and explored the psychometric properties and score interpretability of the NAVQ-P and additional PRO items assessing near vision correction independence (NVCI), near vision satisfaction (NVS), and near vision correction preference (NVCP).

Methods: This was a psychometric validation study conducted using PRO data collected as part of a Phase IIb clinical trial (CUN8R44 A2202) consisting of 235 randomized adults with presbyopia from the US, Japan, Australia, and Canada.

View Article and Find Full Text PDF

Objective: Psychomotor retardation is a core clinical component of Major Depressive Disorder responsible for disability and is known as a treatment response marker of biological treatments for depression. Our objective was to describe cognitive and motoric measures changes during a treatment by repetitive Transcranial Magnetic Stimulation (rTMS) within the THETAD-DEP trial for treatment-resistant depression (TRD), and compare those performances at the end of treatment and one month after between responders (>50% improvement on MADRS score), partial responders (25-50%) and non-reponders (no clinically relevant improvement). Our secondary aim was to investigate baseline psychomotor performances associated with non-response and response even partial.

View Article and Find Full Text PDF

Background: Major depressive disorder is one of the leading causes of disability worldwide. Although most international guidelines recommend psychological and psychosocial interventions as first-line treatment for mild to moderate depression, access remains limited in France due to the limited availability of trained clinicians, high costs for patients in the context of nonreimbursement, and the fear of stigmatization. Therefore, online blended psychological treatment such as Deprexis could improve access to care for people with depression.

View Article and Find Full Text PDF